Cryoablation Devices Market Size & Share 2023 to 2032
Market Size by Type (Probe, Systems), by Application (Cardiology, Oncology), by End Use (Hospitals, Specialty Centers.
Report ID: GMI6025
|
Published Date: June 2023
|
Report Format: PDF
Download Free PDF
Authors:
Mariam Faizullabhoy, Pratiksha Kamthe
Cryoablation Devices Market Size
Cryoablation Devices Market size was valued at over USD 690 million in 2022 and is predicted to reach more than USD 1.5 billion by 2032.
Cryoablation Devices Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Cryoablation devices are medical instruments that are utilized in cryoablation operations. Cryoablation is a procedure that includes freezing and destroying aberrant tissues or cells in the body using extremely low temperatures. A cryoablation console or system as well as a probe or catheter are commonly utilized in cryoablation treatments. Additionally, the rise in healthcare expenditure among developed and emerging economies is projected to contribute to the market growth. Investments in healthcare infrastructure and the availability of reimbursement policies for cryoablation procedures will further facilitate the market expansion.
Continuous advancements in cryoablation devices will act as a significant factor to accelerate the market penetration. The development and launch of advanced technology with inbuilt devices that offer better device performance, accuracy and safety will spur the demand for cryoablation devices. Furthermore, several manufacturers are producing devices with superior cooling processes, enhanced imaging capabilities and improved catheter designs for precise and efficient tissue targeting that will thereby propel the market growth potential.
COVID-19 Impact
The COVID-19 pandemic had moderately negative impact on the cryoablation devices market in 2020. The pandemic disrupted global supply chains led to shortages of medical products, including cryoablation devices. This caused price fluctuations and delayed delivery times that impacted the availability of these products in some regions. As a result, the COVID-19 stifled the expansion of the market. Moreover, during the pandemic, healthcare systems globally faced immense pressure to allocate resources and prioritize COVID-19 patients. As a result, many non-essential procedures, including certain cryoablation treatments were postponed or cancelled. This led to a decline in demand for cryoablation devices as hospitals and clinics focused on urgent and essential care.
However, as vaccination efforts progress and healthcare systems adapt to the new normal there is a rebound in non-essential medical procedures, including cryoablation treatments. The rescheduling of postponed procedures and the increasing focus on cancer and other disease diagnosis and treatment stimulated the demand for cryoablation devices in the year 2021.
Cryoablation Devices Market Trends
The rising prevalence rate of chronic diseases such as cancer and cardiovascular diseases is further augmenting the market progress. For instance, according to the World Health Organization (WHO), cardiovascular diseases are responsible for approximately 17.9 million deaths each year. Similarly, the WHO stated that in 2020, cancer was a leading cause of morbidity across the globe and accounted for more than 10 million deaths worldwide. Further, more than 2.2 million new individuals were diagnosed with lung cancer and around 1.4 million with prostate cancer in the year 2020. Thus, an upsurge in the chronic disease burden around the world is predicted to propel the market demand.
Moreover, the growing preference for minimally invasive procedures among patients and healthcare providers such as cryoablation procedures that offer several benefits such as reduced trauma, shorter recovery times, and lower risk of complications compared to traditional surgical interventions will contribute to the adoption of cryoablation devices.
Cryoablation Devices Market Analysis
Based on type, the cryoablation devices market is bifurcated into probe and systems. The probe segment further subdivided into epidermal and subcutaneous cryoablation systems, tissue contact probe ablators, and tissue spray probe ablators. Systems segment is segregated into generator and accessories & consumables. The probe segment is anticipated to witness highest growth during the forecast period. Continuous technological advancements including probe design improvements, temperature monitoring systems, and imaging techniques enhanced the safety and effectiveness of cryoablation procedures. These advancements will contribute to increase adoption of cryoablation probe segment.
Moreover, tissue contact probe ablators held large market share in 2022. Growing preference for minimally invasive procedures in cancer diagnostics will drive the demand for tissue contact probe ablators. Patients and healthcare providers are seeking treatment options that offer shorter recovery times, reduced complications, and improved patient comfort. Further, tissue contact probe ablators allow precise and targeted ablation while minimizing damage to surrounding tissues thereby, witnessing greater adoption rate.
Cryoablation devices market by application is categorized into cardiology, oncology, and others. Further, cancer segment is subdivided into lung cancer, liver cancer, breast cancer, kidney cancer, prostate cancer, and others. The cancer segment accounting for more than 51% business share in 2022. The high revenue growth is owing to upsurge in cancer prevalence rate worldwide, technological advancements, and growing patient inclination towards minimally invasive therapies. Rising incidence of cancer globally is a primary factor for the market growth. Moreover, as cancer cases continue to grow, the need for effective treatment options increases. Cryoablation gains prominence as a viable treatment modality for various types of cancer including prostate, liver, kidney, lung, and breast, thereby accelerating segment growth potential.
The cryoablation devices market is segmented by end-use into hospitals, specialty centers, ambulatory surgical centers, and others. The hospitals segment crossed more than USD 350 million revenue size in 2022. High segment growth is attributed to rising number of people suffering from several chronic ailments such as cardiovascular diseases and cancer across developing countries. Moreover, integration of advanced ablation devices including cryoablation devices for precise treatment is projected to witness high market demand.
Further, increasing disposable spending and developing healthcare infrastructure in developing nations will contribute considerably towards adoption of cryoablation devices in hospitals thereby positively influencing to segmental progress.
U.S. cryoablation devices market accounted for more than USD 250 million in 2022 and is anticipated to showcase considerable market growth over the estimated timeframe. Growing prevalence of cancer in the U.S. will act as a prominent factor propelling the market in the country. For instance, in 2022, the American Cancer Society estimated that more than 1.9 million new cancer cases were detected in the U.S. Thus, increasing number of cancer population will boost the market size. Further, emerging specialized cryoablation centers in the U.S. that provide specialized expertise, modern equipment, and comprehensive care for patients undergoing cryoablation procedures will bolster the market demand.
Cryoablation Devices Market Share
Some of the eminent market participants operating in the cryoablation devices market include:
These industry players are implementing numerous growth strategies such as collaborations, partnerships, acquisitions & mergers, and new product development & launches to broaden their product portfolio as well as gain a competitive edge over others.
Cryoablation Devices Industry News:
Cryoablation devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Type (USD Million & 000’ Units)
By Application (USD Million)
By End-use (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →